Cytosorbents Corporation (CTSO)
NASDAQ: CTSO
· Real-Time Price · USD
1.04
0.03 (2.97%)
At close: May 01, 2025, 3:59 PM
Cytosorbents Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Grant income Revenue | 777.59K | 1.05M | 796.77K | 59.33K | 6.58K | 3.77K | 245.51K | 191.47K | 292.63K |
| Grant income Revenue Growth | -26.14% | +32.14% | +1242.90% | +801.29% | +74.62% | -98.46% | +28.22% | -34.57% | n/a |
| Other sales Revenue | 26.52K | 11.4K | 24.73K | n/a | n/a | n/a | n/a | n/a | n/a |
| Other sales Revenue Growth | +132.68% | -53.91% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| All Other Countries Revenue | 18.05M | 15.82M | 17.41M |
| All Other Countries Revenue Growth | +14.08% | -9.12% | n/a |
| Germany Revenue | 12.96M | n/a | n/a |
| Germany Revenue Growth | n/a | n/a | n/a |
| United States Revenue | 5.26M | 968.95K | 1.69M |
| United States Revenue Growth | +443.31% | -42.66% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 7B | 7.58M | 8.57M | 9.24M | 9.21M | 8.91M | 9.13M | 8.71M | 9.34M | 9.12M | 9.96M | 11.08M | 8.44M | 10.54M | 8.42M | 9.38M | 7.86M | 7.44M | 6.84M | 7.21M | 6.84M | 5.1M | 5.32M | 7.16M | 4.46M | 6.58M | 4.68M | 4.77M | 3.92M | 3.93M | 2.95M | 4.69M | 2.42M | 2.94M | 2.22M | 2.37M | 1.99M | 1.92M | 2.18M |
| Selling, General, and Administrative Revenue Growth | +92269.51% | -11.51% | -7.30% | +0.37% | +3.36% | -2.44% | +4.83% | -6.78% | +2.48% | -8.46% | -10.12% | +31.30% | -19.91% | +25.21% | -10.23% | +19.27% | +5.72% | +8.79% | -5.17% | +5.37% | +34.18% | -4.16% | -25.70% | +60.61% | -32.27% | +40.70% | -1.84% | +21.62% | -0.23% | +33.27% | -37.22% | +93.97% | -17.81% | +32.35% | -6.05% | +19.06% | +3.35% | -11.70% | n/a |
| Research and Development Revenue | 1.85B | 1.52M | 2.25M | 4.1M | 3.75M | 3.67M | 4.21M | 3.4M | 3.29M | 4.18M | 4.24M | 6.14M | 4.26M | 3.7M | 2.28M | 2.69M | 1.75M | 2.41M | 1.97M | 3.56M | 3.19M | 2.93M | 2.42M | 2.42M | 1.94M | 1.58M | 1.78M | 2.42M | 537.95K | 487.61K | 469.55K | 1.66M | 1.17M | 1.09M | 856.12K | 1.25M | 866.33K | 801.66K | 951.03K |
| Research and Development Revenue Growth | +121722.06% | -32.41% | -45.12% | +9.27% | +2.19% | -12.96% | +23.90% | +3.40% | -21.35% | -1.41% | -30.86% | +43.99% | +15.22% | +62.10% | -15.03% | +53.12% | -27.10% | +22.44% | -44.78% | +11.73% | +8.72% | +21.13% | -0.20% | +24.71% | +23.33% | -11.49% | -26.47% | +350.08% | +10.32% | +3.85% | -71.77% | +41.89% | +7.33% | +27.56% | -31.62% | +44.52% | +8.07% | -15.71% | n/a |
| Sales and Marketing Revenue | 6.99B | -820.73K | -680.71K | -1.31M | 49K | 38K | 55K | 224K | 143K | 115K | 81K | 160K | 151K | 148K | 154K | 167K | 32K | 55K | 31.5K | 99K | 70K | 93K | 51.8K | 86K | 40K | 49K | 36.76K | 30K | 45K | 37K | 49.76K | 20K | 28K | 45K | 79.61K | 82K | 84K | 66K | 51K |
| Sales and Marketing Revenue Growth | -852374.72% | +20.57% | -48.22% | -2782.77% | +28.95% | -30.91% | -75.45% | +56.64% | +24.35% | +41.98% | -49.38% | +5.96% | +2.03% | -3.90% | -7.78% | +421.88% | -41.82% | +74.60% | -68.18% | +41.43% | -24.73% | +79.54% | -39.77% | +115.00% | -18.37% | +33.29% | +22.54% | -33.33% | +21.62% | -25.65% | +148.82% | -28.57% | -37.78% | -43.47% | -2.91% | -2.38% | +27.27% | +29.41% | n/a |